A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

Clinical trial NCT06454175 · UNKNOWN

Trial details

NCT number: NCT06454175
Sponsor: Shanghai Bovax Biotechnology Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

HPV Infection HPV-Related Carcinoma Genital Wart HPV-Related Intraepithelial Neoplasia

Start date: 2024-08-03
Primary completion: 2025-02-05
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.